+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Metabolic inflammation: connecting obesity and insulin resistance



Metabolic inflammation: connecting obesity and insulin resistance



Annals of Medicine 45(3): 242-253



Insulin resistance is a pathological condition that arises when insulin signaling is impaired, forcing β-cells to produce more insulin in order to cope with body demands and to maintain glucose homeostasis. When the pancreas is no more able to support an appropriate insulin secretion, insulin resistance becomes decompensated and hyperglycemia is detected. One of the mechanisms leading to insulin resistance is low-grade inflammation that involves a number of protagonists such as inflammatory cytokines, lipids and their metabolites, reactive oxygen species (ROS), hypoxia and endoplasmic reticulum stress, and changes in gut microbiota profiles. We review here the molecular aspects of metabolic inflammation converging to insulin resistance and secondarily to type 2 diabetes. We also discuss the place of high-sensitivity C-reactive protein (hsCRP) in the assessment of metabolic inflammation and potential therapeutic interventions aimed to impede inflammation and therefore prevent insulin resistance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054340272

Download citation: RISBibTeXText

PMID: 22834949

DOI: 10.3109/07853890.2012.705015


Related references

Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International Journal of Molecular Sciences 15(4): 6184-6223, 2014

Intestinal Microbiota Contributes to Energy Balance, Metabolic Inflammation, and Insulin Resistance in Obesity. Journal of Obesity and Metabolic Syndrome 26(3): 161-171, 2019

Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. American Journal of Physiology. Endocrinology and Metabolism 308(6): E460-E469, 2015

Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. Atherosclerosis 275: 50-57, 2018

An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation. Mediators of Inflammation 2013: 814989, 2013

Adipocytokines: a bridge connecting obesity and insulin resistance. Medical Hypotheses 73(6): 981-985, 2010

Polyunsaturated Fatty acids, insulin resistance, and atherosclerosis: is inflammation the connecting link?. Metabolic Syndrome and Related Disorders 2(2): 124-128, 2008

Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a remedy for metabolic syndrome. International Journal of Environmental Research and Public Health 8(7): 3019-3031, 2011

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. Journal of Internal Medicine 254(1): 32-44, 2003

Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. Plos Genetics 6(5): E1000938, 2010

Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obesity Surgery 13(5): 699-705, 2003

Metabolic predispositions to laminitis in horses and ponies obesity, insulin resistance and metabolic syndromes. Journal Of Equine Veterinary Science: 12, 753-759, 2008

Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diabetes and Vascular Disease Research 8(2): 109-116, 2011

The frequent UCP2 ?866GA polymorphism protects against insulin resistance and is associated with obesity a study of obesity and related metabolic traits among 17?636 Danes. International Journal of Obesity 37(2): 175-181, 2013

Insulin resistance, insulin response, and obesity as indicators of metabolic risk. Journal of Clinical Endocrinology and Metabolism 92(8): 2885-2892, 2007